Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration

Table 1

Patient demographic and baseline characteristics.

Characteristic	Number
Eyes (n)	64
Mean age (range)	70.3 ± 8.5 (53–92)
Women, n (%)	27 (42.1%)
Right eye, n (%)	34 (53.1%)
Type of AMD
Type 1 CNV, n (%)	21 (32.8%)
Type 2 CNV, n (%)	5 (7.8%)
PCV, n (%)	25 (39.1%)
Mixed CNV, n (%)	13 (20.3%)

CNV, choroidal neovascularization; PCV, polypoidal choroidal vasculopathy.